Доступ предоставлен для: Guest
Critical Reviews™ in Immunology

Выходит 6 номеров в год

ISSN Печать: 1040-8401

ISSN Онлайн: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Diverse Functional Activity of CD83+ Monocyte-Derived Dendritic Cells and the Implications for Cancer Vaccines

Том 21, Выпуск 1-3, 2001, 22 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.110
Get accessGet access

Краткое описание

Antigen-loaded dendritic cells (DCs) provide key regulatory signals to T cells during a developing antitumor response. In addition to providing costimulation, mature DC provides cytokine and chemokine signals that can define the T1 vs T2 nature of the antitumor T-cell response as well as whether T cells engage in direct interactions with tumor cells. In serum-free culture conditions that hasten the differentiation of monocytes into mature DCs, certain agents, such as CD40L, accelerate phenotypic maturation (e.g., CD83 and costimulatory molecule expression) without influencing the acquisition of Dc1/Dc2 characteristics. In contrast, exposure to serum-free medium and interferon-g (IFN-g) rapidly influences CD83+ DCs to secrete high levels of IL-12, IL-6, and MIP-1b, and promotes Dc1 differentiation. In contrast, CD83+ DCs matured in serum-free medium in the absence of IFN-g, or in the presence of calcium signaling agents, prostaglandin-E2, or IFN-a, produce no IL-12, scant IL-6, and prodigious IL-8, MDC, and TARC, and promote Dc2 differentiation. T cells sensitized via IL-12–secreting, peptide-pulsed DCs secrete cytokines when subsequently exposed to relevant peptide-pulsed antigen-presenting cells (APCs) or to HLA-compatible tumor cells endogenously expressing the peptide. In contrast, T cells sensitized via IL-12 nonsecreting DC were limited to antigenic reactivation through APC contact rather than tumor cell contact. Therefore, the development of antitumor responses can be dramatically influenced not only by costimulation, but also by the cytokine and chemokine production of DCs, which must be considered in the development of cancer vaccines.

ЦИТИРОВАНО В
  1. Daniel Volker, Naujokat Cord, Sadeghi Mahmoud, Wiesel Manfred, Hergesell Olaf, Opelz Gerhard, Association of Circulating Interleukin (IL)-12– and IL-10–Producing Dendritic Cells with Time Posttransplant, Dose of Immunosuppression, and Plasma Cytokines in Renal-Transplant Recipients, Transplantation, 79, 11, 2005. Crossref

  2. Kirkwood John M., Butterfield Lisa H., Tarhini Ahmad A., Zarour Hassane, Kalinski Pawel, Ferrone Soldano, Immunotherapy of cancer in 2012, CA: A Cancer Journal for Clinicians, 62, 5, 2012. Crossref

  3. SVANE INGE MARIE, SOOT METTE LINE, BUUS SOREN, JOHNSEN HANS E., Clinical application of dendritic cells in cancer vaccination therapy, APMIS, 111, 7-8, 2003. Crossref

  4. Brusa Davide, Carletto Sara, Cucchiarale Giuseppina, Gontero Paolo, Greco Alessandro, Simone Mariagrazia, Ferrando Ugo, Tizzani Alessandro, Matera Lina, Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes, The Prostate, 71, 4, 2011. Crossref

  5. Tangen Jon-Magnus, AMA Tryggestad, G Hetland, Stimulation of human monocytic cells by the medicinal mushroom Agaricus blazei Murill induces expression of cell surface markers associated with activation and antigen presentation, Applied Scientific Reports, 1, 1, 2014. Crossref

  6. Faries Mark B., Czerniecki Brian J., Dendritic cells in melanoma immunotherapy, Current Treatment Options in Oncology, 6, 3, 2005. Crossref

  7. Han Ruiling, Zhu Junming, Yang Xiangliang, Xu Huibi, Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells, Journal of Biomedical Materials Research Part A, 96A, 1, 2011. Crossref

  8. Holmstrøm Kim, Pedersen Ayako Wakatsuki, Claesson Mogens Helweg, Zocca Mai-Britt, Jensen Simon Skjøde, Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy, Human Immunology, 71, 1, 2010. Crossref

  9. Schaue Dörthe, Kachikwu Evelyn L., McBride William H., Cytokines in Radiobiological Responses: A Review, Radiation Research, 178, 6, 2012. Crossref

  10. Kalinski Pawel, Mailliard Robbie B, Giermasz Adam, Zeh Herbert J, Basse Per, Bartlett David L, Kirkwood John M, Lotze Michael T, Herberman Ronald B, Natural killer–dendritic cell cross-talk in cancer immunotherapy, Expert Opinion on Biological Therapy, 5, 10, 2005. Crossref

  11. Michielsen Adriana J., Hogan Andrew E., Marry Joseph, Tosetto Miriam, Cox Fionnuala, Hyland John M., Sheahan Kieran D., O'Donoghue Diarmuid P., Mulcahy Hugh E., Ryan Elizabeth J., O'Sullivan Jacintha N., Dieli Francesco, Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer, PLoS ONE, 6, 11, 2011. Crossref

  12. Osada Takuya, Clay Timothy M., Woo Christopher Y., Morse Michael A., Lyerly H. Kim, Dendritic Cell-Based Immunotherapy, International Reviews of Immunology, 25, 5-6, 2006. Crossref

  13. Janic Branislava, Iskander A. S. M., Rad Ali M., Soltanian-Zadeh Hamid, Arbab Ali S., Feldmesser Marta, Effects of Ferumoxides – Protamine Sulfate Labeling on Immunomodulatory Characteristics of Macrophage-like THP-1 Cells, PLoS ONE, 3, 6, 2008. Crossref

  14. Park Shin-Young, Choi Woo Hyuck, Kim Yong Bum, Ha Chang Su, Lee Hyunah, Kwon Young-Do, Choi Ok-Mi, Lee Young-Joon, Koh Woo Suk, Potential Side Effects of Dendritic Cells Pulsed with Allogenic Melanoma Cell Lysate in Mice, International Journal of Toxicology, 26, 1, 2007. Crossref

  15. Anguille Sébastien, Smits Evelien L., Bryant Christian, Van Acker Heleen H., Goossens Herman, Lion Eva, Fromm Phillip D., Hart Derek N., Van Tendeloo Viggo F., Berneman Zwi N., Rosenblum Michael G., Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy, Pharmacological Reviews, 67, 4, 2015. Crossref

  16. Robson Neil C., Phillips David J., McAlpine Tristan, Shin Amanda, Svobodova Suzanne, Toy Tracey, Pillay Vinochani, Kirkpatrick Naomi, Zanker Damien, Wilson Kathy, Helling Imke, Wei Heng, Chen Weisan, Cebon Jonathan, Maraskovsky Eugene, Activin-A: a novel dendritic cell–derived cytokine that potently attenuates CD40 ligand–specific cytokine and chemokine production, Blood, 111, 5, 2008. Crossref

  17. Kalinski Pawel, Wieckowski Eva, Muthuswamy Ravikumar, de Jong Esther, Generation of Stable Th1/CTL-, Th2-, and Th17-Inducing Human Dendritic Cells, in Dendritic Cell Protocols, 595, 2010. Crossref

  18. Katzman Shoshana D., Gallo Eugenio, Hoyer Katrina K., Abbas Abul K., Differential Requirements for Th1 and Th17 Responses to a Systemic Self-Antigen, The Journal of Immunology, 186, 8, 2011. Crossref

  19. Faries Mark B, Morton Donald L, Therapeutic Vaccines for Melanoma, BioDrugs, 19, 4, 2005. Crossref

  20. Okur Fatma V., Brenner Malcolm K., Cellular Immunotherapy of Cancer, in Immunotherapy of Cancer, 651, 2010. Crossref

  21. Kalinski Pawel, Urban Julie, Narang Rahul, Berk Erik, Wieckowski Ewa, Muthuswamy Ravikumar, Dendritic cell-based therapeutic cancer vaccines: what we have and what we need, Future Oncology, 5, 3, 2009. Crossref

  22. PONSAERTS P, VAN TENDELOO V F I, BERNEMAN Z N, Cancer immunotherapy using RNA-loaded dendritic cells, Clinical and Experimental Immunology, 134, 3, 2003. Crossref

  23. Prabakaran Indira, Menon Chandrakala, Xu Shuwen, Gómez-Yafal Alicia, Czerniecki Brian J., Fraker Douglas L., Mature CD83+ dendritic cells infected with recombinant gp 100 vaccinia virus stimulate potent antimelanoma T cells, Annals of Surgical Oncology, 9, 4, 2002. Crossref

  24. Xu Shuwen, Koski Gary K., Faries Mark, Bedrosian Isabelle, Mick Rosemarie, Maeurer Markus, Cheever Martin A., Cohen Peter A., Czerniecki Brian J., Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism , The Journal of Immunology, 171, 5, 2003. Crossref

  25. Ponsaerts Peter, Van den Bosch Glenn, Cools Nathalie, Van Driessche Ann, Nijs Griet, Lenjou Marc, Lardon Filip, Van Broeckhoven Christine, Van Bockstaele Dirk R., Berneman Zwi N., Van Tendeloo Viggo F. I., Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells, The Journal of Immunology, 169, 4, 2002. Crossref

Статьи, принятые к публикации

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain